医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

UpToDate Recognized by Japan Primary Care Association as Continuing Medical Education Resource

2015年06月17日 PM10:30
このエントリーをはてなブックマークに追加


 

WALTHAM, Mass.

Wolters Kluwer, a leading global provider of information and point of care solutions for the healthcare industry, announced today that UpToDate®, its acclaimed clinical decision support resource, has received approval from the Japan Primary Care Association (JPCA) as an official Continuing Medical Education (CME) resource. JPCA members can now earn CME credits while using UpToDate to answer clinical questions.

“The flow of medical knowledge is ever-increasing, but physicians do not have the time to keep up with constantly changing information,” said Mr. Atsushi Igaki, Chief Administrative Officer of the JPCA. “UpToDate helps manage this challenge by promoting continuous learning. With every search on UpToDate, members of the JPCA can provide the best care for their patients while continuing their medical education.”

Studies have shown that researching clinical information in UpToDate helps doctors stay current with changes in research and recommended treatments across 22 specialties. JPCA physicians can now use the time they already spend researching clinical questions with UpToDate toward continuing professional development requirements at no extra cost and with no additional testing. Recognized by the JPCA as a provider of internet point of care learning, UpToDate use can be applied to JPCA members’ 5-year certification period.

Using UpToDate to fulfill CME requirements is easier than ever at hospitals and institutions where UpToDate Anywhere is available. JPCA members can access UpToDate on mobile devices using award-winning mobile apps. UpToDate may also be integrated in the electronic medical record (EMR) system which streamlines both the clinical workflow and access to CME/CE/CPD.

“We are honored to provide a continuing medical education resource for the Japan Primary Care Association,” says Denise Basow, MD, Vice President and General Manager, UpToDate at Wolters Kluwer Health, Clinical Solutions. “Studies have demonstrated that clinical knowledge declines over the career of a physician. UpToDate can mitigate this trend by providing current and evidence-based content that ensures physicians make the right decisions and provide the highest quality of care.”

Wolters Kluwer continues to work with professional societies in Japan to facilitate access to innovative continuing medical education via UpToDate.

To learn more about the JPCA, please visit: http://www.primary-care.or.jp. For more details about how UpToDate usage is recognized by the JPCA, please visit: http://www.uptodate.com/home/cmececpd-accreditations.

Follow UpToDate on Facebook, Twitter and LinkedIn.

About Wolters Kluwer

Wolters Kluwer is a global leader in professional information services. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance and healthcare rely on Wolters Kluwer’s market leading information-enabled tools and software solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world.

Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group serves customers in over 170 countries, and employs over 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands. Wolters Kluwer shares are listed on NYSE Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).

For more information about our products and organization, visit www.wolterskluwer.com, follow @WKHealth or @Wolters_Kluwer on Twitter, like us on Facebook, follow us on LinkedIn, or follow WoltersKluwerComms on YouTube.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150617005132/en/

CONTACT

Media:
Wolters Kluwer | UpToDate
André Rebelo, +1
781-392-2411
Public & Analyst Relations Manager
andre.rebelo@wolterskluwer.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-402の第I相中間データを発表
  • Vedanta Biosciences Granted Four New U.S. Patents Expanding Coverage for Compositions and Methods of Use for Therapeutics Based on Microbiome-Derived Bacterial Consortia
  • Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in HER2-Mutated Cancer
  • 武田和Seattle Genetics呈报3期ECHELON-1临床试验的阳性数据,该试验评估ADCETRIS® (brentuximab vedotin)用于晚期霍奇金淋巴瘤的一线治疗
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-301の第I相中間データを発表